Expression analysis of ER-modulated genes (Supplementary Table 2) in short-term treatment-sensitive tumours showed that fulvestrant and AZD9496, at 5 and/or 50 mg/kg, significantly modulated ER-dependent gene expression in comparison to tamoxifen (Fig. 4d). This evidence concerns the gene ESR1 and neoplasm.